Showing results (31-40 of 277) with videos related to
Sort By:
Pageof 28
Clinical Lung Cancer|May 26, 2022
Quantifying The Medical Impact of A Missed Diagnosis of Non-Small Cell Lung Cancer on Chest ImagingD Ross Camidge, Divneet Mandair, Rustain Morgan, et al.Rare Tumors|November 17, 2025
Durable response with mutation-guided ALK inhibition in a patient with metastatic epithelioid inflammatory myofibroblastic sarcoma: A case reportSumra S Chaudhry, D Ross Camidge, Michael R Clay, et al.Translational Lung Cancer Research|January 13, 2023
PD-1/PD-L1 inhibitor activity in patients with gene-rearrangement positive non-small cell lung cancer-an IMMUNOTARGET case seriesRao Mushtaq, Alexis B Cortot, Oliver Gautschi, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 21, 2019
Management Strategies for Early-Onset Pulmonary Events Associated with BrigatinibD Ross Camidge, Aliyah Pabani, Ronni M Miller, et al.Oncology (Williston Park, N.Y.)|May 30, 2009
Surprised by stage III: unexpected N2 lymph node involvement found during surgery for early-stage NSCLCScott A Kono, Michael Weyant, Wilbur Franklin, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2014
Crizotinib effects on creatinine and non-creatinine-based measures of glomerular filtration rateD Ross Camidge, Evelyn M Brosnan, Chamath DeSilva, et al.Targeted Oncology|August 26, 2018
Targeted Therapies in the Treatment of SarcomasBrianna Hoffner, Anthony D Elias, Victor M VillalobosJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 6, 2020
Early-Onset Pulmonary Events Associated With Brigatinib Use in Advanced NSCLCTerry L Ng, Narayana Narasimhan, Neeraj Gupta, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 4, 2016
A Brief Report of the Status of Central Nervous System Metastasis Enrollment Criteria for Advanced Non-Small Cell Lung Cancer Clinical Trials: A Review of the ClinicalTrials.gov Trial RegistryCaroline E McCoach, Eamon M Berge, Xian Lu, et al.Lung Cancer (Amsterdam, Netherlands)|January 23, 2010
New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancerRobert C Doebele, Ana B Oton, Nir Peled, et al.Pageof 28